NCT06898450 2026-04-22A Study to Assess the Safety, Tolerability, and Efficacy of NDI-219216 in Patients With Advanced Solid Tumors.Nimbus TherapeuticsPhase 1/2 Recruiting134 enrolled
NCT06004245 2026-04-07A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid TumorsVividion Therapeutics, Inc.Phase 1 Recruiting280 enrolled